- Vascular Solutions (NASDAQ:VASC +2%) Q3 results : Revenues: $31.9M (13.9%); COGS: $10.3M (12.0%); R&D Expense: $3.3M (6.5%); SG&A: $11M (20.9%); Operating Income: $5.2M (30.0%); Net Income: $2.6M (-3.7%); EPS: $0.15 (-6.25%); Quick Assets: $41.7M (35.4%).
- 2014 Guidance: Revenues: $125M - 126M from $123M - 125M; EPS: $0.65 - 0.67 from $0.73 - 0.77.
- Q4 Guidance: Revenues: $32.5M - $33.5M; EPS: $0.16 - $0.18.